Outset Medical (OM) Net Equity Issued and Repurchased (2020)
Outset Medical (OM) posted quarterly Net Equity Issued and Repurchased of $128.0 million for Q4 2020, up 1.02% quarter-over-quarter from $126.8 million in Q1 2020.
Outset Medical (OM) Net Equity Issued and Repurchased (2020) Analysis & Trends
Outset Medical (OM) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $128.0 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Net Equity Issued and Repurchased changed N/A year-over-year to $128.0 million; the TTM figure through Sep 2022 stood at $128.0 million (changed 0.0% YoY), while the FY2021 annual figure was $149.1 million, down 41.49% from the prior year.
- Net Equity Issued and Repurchased climbed to $128.0 million in Q4 2020 per OM's latest filing, from $126.8 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $128.0 million in Q4 2020 and bottomed at $126.8 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Outset Medical | 80.25 Mn | -182.94 Mn | 13.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 128.05 Mn |
| Dec 31, 2020 | 128.05 Mn |
| Mar 31, 2020 | 126.76 Mn |
| Mar 31, 2020 | 126.76 Mn |